| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |